when compared with LA alone <strong>and</strong> sal<strong>in</strong>e controlgroups (41).Dexmedetomid<strong>in</strong>e (IV) may reduce opioid requirements<strong>and</strong> respiratory side effects <strong>in</strong> children after tonsillectomy,this may particularly benefit those withobstructive sleep apnea (OSA) or respiratory compromise.One microgram per kilogram produced less respiratorydepression than 100 lgÆkg )1 morph<strong>in</strong>e but lesseffective analgesia (50). Higher doses, 2 <strong>and</strong> 4 lgÆkg )1 ,lengthened time to rescue opioid analgesia but<strong>in</strong>creased sedation <strong>in</strong> the early postoperative periodwhen compared to fentanyl 1 or 2 lgÆkg )1 IV (51).Dexmedetomid<strong>in</strong>e 2 lgÆkg )1 + 0.7 lgÆkg )1 Æh )1 <strong>in</strong>traoperativereduced early postoperative opioid requirements<strong>and</strong> agitation <strong>in</strong> children with OSA comparedwith fentanyl 1 lgÆkg )1 (52).Dexamethasone reduces PONV <strong>and</strong> postoperativepa<strong>in</strong> scores follow<strong>in</strong>g tonsillectomy (13,53).Most meta-analyses of posttonsillectomy analgesiahave focused on PONV <strong>and</strong> bleed<strong>in</strong>g rather than analgesicefficacy. PONV follow<strong>in</strong>g tonsillectomy is reducedby NSAID presumably because of a reduction <strong>in</strong>opioid requirement (33,54), <strong>and</strong> by <strong>in</strong>traoperative dexamethasone(see above). As posttonsillectomy bleed<strong>in</strong>gis relatively rare, meta-analyses have <strong>in</strong>cluded differenttrials <strong>and</strong> reached different conclusions:l Bleed<strong>in</strong>g is <strong>in</strong>creased by aspir<strong>in</strong> but not ibuprofen ordiclofenac (seven trials) (55).l Risk of bleed<strong>in</strong>g <strong>and</strong> reoperation <strong>in</strong>creased (NNH29), <strong>and</strong> NSAIDS should not be used (seven trials)(56).l Risk of reoperation (NNH 60) but not bleed<strong>in</strong>g<strong>in</strong>creased, <strong>and</strong> NSAIDS should be used cautiously (25trials) (33)l NSAIDS do not <strong>in</strong>crease risk of bleed<strong>in</strong>g or reoperationbut further studies required (13 pediatric trials)(54).Although meta-analyses are currently <strong>in</strong>conclusive,perioperative diclofenac <strong>and</strong> ibuprofen appear to beassociated with m<strong>in</strong>imal risk of posttonsillectomybleed<strong>in</strong>g. Early studies us<strong>in</strong>g high doses of ketorolachave been <strong>in</strong>cluded <strong>in</strong> the meta-analyses, but there are<strong>in</strong>sufficient data to assess the risks associated with differentNSAIDS.Analgesia Table 5.2.2AgentTechniqueDirectevidenceLA a Tonsillar fossa <strong>in</strong>jection 1+*Topical 1+*Opioid 1+Tramadol 1+Dexamethasone 1+Ketam<strong>in</strong>e 1+NSAIDS 1+Paracetamol 1+a No differences have been demonstrated based on route (topicalvs <strong>in</strong>filtration), type of LA, or time of <strong>in</strong>jection (pre- vs postremoval).5.2.3 Mastoid <strong>and</strong> middle ear surgeryMastoidectomy may be performed to remove <strong>in</strong>fectedtissue or cholesteatoma. As the <strong>in</strong>cidence of chronicsuppurative otitis media is decl<strong>in</strong><strong>in</strong>g <strong>in</strong> many populations,this surgery is now less frequently required <strong>in</strong>the UK. Middle ear surgery, such as reconstruction ofa damaged tympanic membrane by placement of surgicalgrafts, may be associated with significant PONV.See also section 5.1 for the general management ofpostoperative pa<strong>in</strong>.RecommendationsGreat auricular nerve block can provide similar analgesia<strong>and</strong> reduced PONV compared with morph<strong>in</strong>e. Pre<strong>in</strong>cisiontim<strong>in</strong>g of the block confers no additional benefit:Grade B (57,58).EvidenceThere are relatively few controlled trials specifically<strong>in</strong>vestigat<strong>in</strong>g pa<strong>in</strong> dur<strong>in</strong>g <strong>and</strong> after mastoidectomy <strong>and</strong><strong>in</strong>vasive middle ear surgery, <strong>and</strong> no further studiess<strong>in</strong>ce the last edition of this guidel<strong>in</strong>e. As NSAIDS<strong>and</strong> paracetamol improve analgesia for middle ear procedures,there is <strong>in</strong>direct evidence that they providebeneficial supplemental analgesia for mastoid surgery.However, compared with middle ear surgery, mastoidsurgery is associated with <strong>in</strong>creased pa<strong>in</strong>: patients aretherefore more likely to require opioids, treatment forPONV <strong>and</strong> hospital admission (59). In procedures thatrequire a postauricular <strong>in</strong>cision, LA block of the greatauricular nerve can provide similar analgesia <strong>and</strong>reduced PONV compared with morph<strong>in</strong>e (57). No differencewas found between perform<strong>in</strong>g the block pre<strong>in</strong>cisionvs prior to the end of surgery (58).36 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79
Analgesia Table 5.2.3AgentTechniqueDirectevidenceLAGreater auricular 1)nerve blockOpioid 1)NSAID 1)Paracetamol 1)5.3 Opthalmology5.3.1 Strabismus surgeryIndirectevidenceStrabismus surgery (correction of squ<strong>in</strong>t) is associatedwith a high <strong>in</strong>cidence of PONV, <strong>and</strong> <strong>in</strong>traoperativetension on ocular muscles may provoke a vagalresponse (oculocardiac reflex). See also section 5.1 forthe general management of postoperative pa<strong>in</strong>.RecommendationsIntraoperative LA blocks (subtenon’s or peribulbar)reduce PONV <strong>and</strong> may improve perioperative analgesia<strong>in</strong> comparison with IV opioid but provide no benefit overtopical LA: Grade B (60–64).Topical NSAIDS do not improve pa<strong>in</strong> scores or postoperativeanalgesic requirements when compared with topicalLA or placebo: Grade B (65–67).Intraoperative opioid <strong>and</strong> NSAID provide similar postoperativeanalgesia, but opioid use is associated with<strong>in</strong>creased PONV: Grade B (68–71).EvidenceIn many trials, reduction of PONV rather thanimprovement <strong>in</strong> analgesia has been the primary outcome.The duration of surgery varies from 25 to80 m<strong>in</strong> <strong>in</strong> the reported studies, <strong>and</strong> many do not discrim<strong>in</strong>atebetween unilateral or bilateral surgery orprocedures <strong>in</strong>volv<strong>in</strong>g s<strong>in</strong>gle or multiple muscles. Thismay contribute to the variability across studies <strong>in</strong> the<strong>in</strong>cidence of side effects <strong>and</strong> analgesic requirements.Peribulbar or subtenon’s LA blocks reduce <strong>in</strong>traoperativeoculocardiac reflex responses (60,62,63) <strong>and</strong> PONV(60,62,63) when compared with <strong>in</strong>traoperative opioid.Peribulbar or subtenon blocks reduce perioperative analgesicrequirements when compared with opioid <strong>in</strong> some(60,63) but not all (61,62) trials. No complications of LA<strong>in</strong>jections were reported <strong>in</strong> these studies, but patientnumbers are small. Sub-tenon’s block provided no benefitcompared with less <strong>in</strong>vasive topical tetraca<strong>in</strong>e application(64). Topical LA applied prior to <strong>and</strong> at thecompletion of surgery reduced early distress (first30 m<strong>in</strong>) but did not <strong>in</strong>fluence pa<strong>in</strong> at later time po<strong>in</strong>ts orreduce supplemental analgesic requirements (72).No difference <strong>in</strong> postoperative pa<strong>in</strong> scores or analgesicrequirement has been detected between topical LAdrops <strong>and</strong> topical NSAIDS (65,67). Pa<strong>in</strong> scores (CHE-OPS) were not reduced by topical NSAIDS when comparedwith placebo (66,67), but the authors questionedthe sensitivity of this measure for ocular pa<strong>in</strong>.Direct comparisons of <strong>in</strong>traoperative NSAID <strong>and</strong>opioid (PR diclofenac vs IV morph<strong>in</strong>e) (71) (IV ketorolacvs IV pethid<strong>in</strong>e) (70) (IV ketorolac vs IV fentanyl)(68) have reported no difference <strong>in</strong> postoperative pa<strong>in</strong>scores or supplemental analgesic requirements but<strong>in</strong>creases <strong>in</strong> PONV <strong>in</strong> patients given opioids. Comparisonof <strong>in</strong>traoperative remifentanil <strong>and</strong> fentanyl reportedhigher early pa<strong>in</strong> scores but less PONV with remifentanil(73). Comparisons of NSAID <strong>and</strong> placebo haveshown m<strong>in</strong>or improvements <strong>in</strong> pa<strong>in</strong> score <strong>and</strong> reductions<strong>in</strong> supplemental analgesic requirements (69,74).Analgesia Table 5.3.1AgentTechniqueDirectevidenceLA Subtenon block a 1)LA Peribulbar a 1)LA Topical a 1+Opioid Parenteral b 1)NSAID Topical 1)Systemic b 1)Paracetamol 1)Indirectevidencea Few comparisons, but no advantage of subtenon over topical<strong>in</strong> one trial.b Similar analgesia with systemic NSAID <strong>and</strong> opioid but<strong>in</strong>creased PONV with opioid; oral or rectal paracetamol givenas part of multimodal analgesia to all patients <strong>in</strong> several trialsbut efficacy not directly compared with other agents.5.3.2 Vitreoret<strong>in</strong>al surgeryVitreoret<strong>in</strong>al <strong>and</strong> ret<strong>in</strong>al detachment surgery are associatedwith significant postoperative pa<strong>in</strong> <strong>and</strong> PONV.Supplemental local anesthetic techniques may have arole, but the relative benefit vs risk has not been fullyevaluated. See also section 5.1 for the general managementof postoperative pa<strong>in</strong>.RecommendationsIn vitreoret<strong>in</strong>al surgery, NSAID can provide similaranalgesia but lower rates of PONV compared with opioid:Grade C (75).ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 37
- Page 1 and 2: PediatricAnesthesiaVolume 22 Supple
- Page 3 and 4: doi: 10.1111/j.1460-9592.2012.3838.
- Page 5 and 6: 1.6 Contact informationCorresponden
- Page 7 and 8: RecommendationsChildren’s self-re
- Page 9 and 10: Topical anesthetic preparations, fo
- Page 11 and 12: 2.7.6 Laparoscopic surgeryGood prac
- Page 13 and 14: In order to assess pain, effective
- Page 16 and 17: Postoperative painl NCCPC-PV (Non-C
- Page 18 and 19: 68 Broome ME, Richtsmeier A, Maikle
- Page 20 and 21: however, reductions in the response
- Page 22 and 23: increased success rate (i.e., less
- Page 24 and 25: Newer preparations such as liposoma
- Page 26 and 27: Good practice pointLubricant contai
- Page 28 and 29: most effective. There are a number
- Page 30 and 31: 12 Bellieni C, Bagnoli F, Perrone S
- Page 32 and 33: venipuncture pain in a pediatric em
- Page 34 and 35: 172 van Twillert B, Bremer M, Faber
- Page 36 and 37: necessary to ensure that the patien
- Page 40 and 41: Peribulbar block improves early ana
- Page 42 and 43: Analgesia Table 5.5.1 Sub-umbilical
- Page 44 and 45: was more effective with less motor
- Page 46 and 47: with using landmark techniques (205
- Page 48 and 49: Good practice pointWound infiltrati
- Page 50 and 51: Analgesia Table 5.6.4 Urological Su
- Page 52 and 53: (298). Ketorolac did not influence
- Page 54 and 55: well as the epidural technique for
- Page 56 and 57: Good practice pointA multi-modal an
- Page 58 and 59: 14 Grainger J, Saravanappa N. Local
- Page 60 and 61: day-stay unit. Int J Paediatr Dent
- Page 62 and 63: tinuous epidural infusion in childr
- Page 64 and 65: 245 Morton NS, O’Brien K. Analges
- Page 66 and 67: 321 Taenzer AH, Clark C, Taenzer AH
- Page 68 and 69: Section 6.0AnalgesiaContents6.1 Ana
- Page 70 and 71: enhance systemic absorption. Lidoca
- Page 73 and 74: undergoes hepatic biotransformation
- Page 75 and 76: tein binding are reduced and the ha
- Page 77 and 78: a low-dose infusion but the child m
- Page 79 and 80: Table 6.6.1 Paracetamol dosing guid
- Page 81: steps that health care professional